Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 5, 2024

Accession no.
0001628280-24-045328
Filed
Nov 5, 2024
Trade date
Oct 1-31, 2024
Filing delay
35 daysLate
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.11K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2024Common StockPPurchaseAcquired+309$1.27+$392.43256,800Direct
Oct 2, 2024Common StockPPurchaseAcquired+309$1.29+$398.61257,109Direct
Oct 3, 2024Common StockPPurchaseAcquired+309$1.28+$395.52257,418Direct
Oct 4, 2024Common StockPPurchaseAcquired+309$1.28+$395.52257,727Direct
Oct 7, 2024Common StockPPurchaseAcquired+309$1.29+$398.61258,036Direct
Oct 8, 2024Common StockPPurchaseAcquired+309$1.30+$401.7258,345Direct
Oct 9, 2024Common StockPPurchaseAcquired+309$1.31+$404.79258,654Direct
Oct 10, 2024Common StockPPurchaseAcquired+309$1.32+$407.88258,963Direct
Oct 11, 2024Common StockPPurchaseAcquired+309$1.39+$429.51259,272Direct
Oct 14, 2024Common StockPPurchaseAcquired+309$1.37+$423.33259,581Direct
Oct 15, 2024Common StockPPurchaseAcquired+309$1.30+$401.7259,890Direct
Oct 16, 2024Common StockPPurchaseAcquired+309$1.25+$386.25260,199Direct
Oct 17, 2024Common StockPPurchaseAcquired+309$1.30+$401.7260,508Direct
Oct 18, 2024Common StockPPurchaseAcquired+309$1.28+$395.52260,817Direct
Oct 21, 2024Common StockPPurchaseAcquired+309$1.25+$386.25261,126Direct
Oct 22, 2024Common StockPPurchaseAcquired+309$1.25+$386.25261,435Direct
Oct 23, 2024Common StockPPurchaseAcquired+309$1.26+$389.34261,744Direct
Oct 24, 2024Common StockPPurchaseAcquired+309$1.24+$383.16262,053Direct
Oct 25, 2024Common StockPPurchaseAcquired+309$1.23+$380.07262,362Direct
Oct 28, 2024Common StockPPurchaseAcquired+309$1.25+$386.25262,671Direct
Oct 29, 2024Common StockPPurchaseAcquired+309$1.24+$383.16262,980Direct
Oct 30, 2024Common StockPPurchaseAcquired+309$1.32+$407.88263,289Direct
Oct 31, 2024Common StockPPurchaseAcquired+309$1.20+$370.8263,598Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)